Ablation of the Pulmonary Artery With High Pulmonary Hypertension During Mitral Valve Surgery
Surgical Ablation of Ganglion Plexuses of the Pulmonary Artery in Patients With Valvular Heart Disease, Complicated by High Pulmonary Hypertension May Reduce Its Degree.
Sponsor: Meshalkin Research Institute of Pathology of Circulation
Listed as NCT02374229, this PHASE1 trial focuses on Pulmonary Hypertension and remains ongoing. Sponsored by Meshalkin Research Institute of Pathology of Circulation, it has been updated 7 times since 2015, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Unknown PHASE1
-
Sep 2024 — Sep 2025 [monthly]
Unknown PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE1
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE1
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE1
▶ Show 2 earlier versions
-
Oct 2017 — Jun 2018 [monthly]
Unknown Status PHASE1
Status: Recruiting → Unknown Status
-
Jan 2017 — Oct 2017 [monthly]
Recruiting PHASE1
First recorded
Feb 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Meshalkin Research Institute of Pathology of Circulation
For direct contact, visit the study record on ClinicalTrials.gov .